Review
Open access
2026
Prognostic value of androgen receptor expression in triple-negative breast cancer: a systematic review and meta-analysis
Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by the absence of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) expression, with limited therapeutic options. TNBC exhibits high tumor heterogeneity and a worse prognosis, including...
Vyvian Paes de Oliveira, Deborah Abucarma Soares, M. E. T. Mendes et al.
· Mastology · 0 citations